We are proudly announcing interested public that we have developed the first cannabinoid formulation for hormone-positive breast cancer in collaboration with the International Institute for Cannabinoids ICANNA. It is intended for “add on” treatment and not for wider use without medical supervision. The development of the formulation was co-financed by the Slovene Enterprise Fund. Breast

“Light” cannabis appears to substitute many drug classes in Italy A recent study sowed a correlation with availability of light cannabis on the Italian market and decreased number of prescribed drugs for a vast number of diseases. What is light cannabis? It is essentially medicinal cannabis with low (legal) amounts of THC (usually 0,2%) and a